Cite
Supplementary Figure 1 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
MLA
Danilo Perrotti, et al. Supplementary Figure 1 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24fd94f3aa38470ee61de153c6daed2c&authtype=sso&custid=ns315887.
APA
Danilo Perrotti, Bruno Calabretta, Maria R. Baer, Xiaoxuan Fan, Ying Zou, Katerina Machova Polakova, Jianfei Qi, Guido Marcucci, Jane F. Apperley, Dragana Milojkovic, Francesco Dazzi, Christopher Harman, Garrett Fitzgerald, Michael W. Deininger, Peter Hokland, Martin Guimond, Moutuaata M. Moutuou, Denis-Claude Roy, Ramiro Garzon, … Giovannino Silvestri. (2023). Supplementary Figure 1 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Chicago
Danilo Perrotti, Bruno Calabretta, Maria R. Baer, Xiaoxuan Fan, Ying Zou, Katerina Machova Polakova, Jianfei Qi, et al. 2023. “Supplementary Figure 1 from Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24fd94f3aa38470ee61de153c6daed2c&authtype=sso&custid=ns315887.